PIK3CA and ductal breast carcinoma in situ: PIK3CA mutations are thought to arise early in cancer development and to be selected for throughout breast cancer progression, as they can be found in ductal carcinoma in situ as well as invasive primary breast cancers and metastatic samples [7].